EP2964211A4 - PREPARATION FOR THE PREVENTION OR TREATMENT OF DIABETES - Google Patents

PREPARATION FOR THE PREVENTION OR TREATMENT OF DIABETES

Info

Publication number: EP2964211A4
Authority: EP; European Patent Office
Prior art keywords: diabetes; prevention; preparation; treatment
Prior art date: 2013-03-06
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP14760276.7A

Other languages

German (de)

French (fr)

Other versions

EP2964211A1 (en

Inventor

Eun Ji Kim

Hye Jung Park

Sang Jun Youn

Hyo Ju Park

Min Ju Hong

Hyo Ju Pyo

Yun Ah Jung

Hyun Wook Park

Yun Jung Kim

Geun Seog Song

Byoung Seok Moon

Kwi Man Kang

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

HK Inno N Corp

Original Assignee

CJ Healthcare Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2013-03-06

Filing date

2014-02-24

Publication date

2016-08-31

2014-02-24 Application filed by CJ Healthcare Corp filed Critical CJ Healthcare Corp

2016-01-13 Publication of EP2964211A1 publication Critical patent/EP2964211A1/en

2016-08-31 Publication of EP2964211A4 publication Critical patent/EP2964211A4/en

Status Withdrawn legal-status Critical Current

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/133—Amines having hydroxy groups, e.g. sphingosine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Cardiology (AREA)
Diabetes (AREA)
Hospice & Palliative Care (AREA)
Heart & Thoracic Surgery (AREA)
Endocrinology (AREA)
Hematology (AREA)
Obesity (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Otolaryngology (AREA)
Molecular Biology (AREA)
Emergency Medicine (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

EP14760276.7A 2013-03-06 2014-02-24 PREPARATION FOR THE PREVENTION OR TREATMENT OF DIABETES Withdrawn EP2964211A4 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
KR1020130024157A KR101336499B1 (en)	2013-03-06	2013-03-06	Combination composition for prevention or treatment of diabetes
PCT/KR2014/001455 WO2014137090A1 (en)	2013-03-06	2014-02-24	Formulation for prevention or treatment of diabetes

Publications (2)

Publication Number	Publication Date
EP2964211A1 EP2964211A1 (en)	2016-01-13
EP2964211A4 true EP2964211A4 (en)	2016-08-31

Family

ID=49987171

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP14760276.7A Withdrawn EP2964211A4 (en)	2013-03-06	2014-02-24	PREPARATION FOR THE PREVENTION OR TREATMENT OF DIABETES

Country Status (9)

Country	Link
EP (1)	EP2964211A4 (en)
JP (1)	JP2016509065A (en)
KR (1)	KR101336499B1 (en)
CN (1)	CN104027328A (en)
BR (1)	BR112015018934A2 (en)
HK (1)	HK1212587A1 (en)
PH (1)	PH12014500736A1 (en)
TW (1)	TW201434463A (en)
WO (1)	WO2014137090A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN118448058B (en) *	2024-06-26	2024-09-27	四川大学华西医院	Prediction system and construction method of diabetes and hypertension based on gastrointestinal electrical signals

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6586438B2 (en) *	1999-11-03	2003-07-01	Bristol-Myers Squibb Co.	Antidiabetic formulation and method
US20080207490A1 (en) *	2005-07-07	2008-08-28	Postech Foundation	Glucose Uptake Modulator and Method for Treating Diabetes or Diabetic Complications
CN101590007A (en) *	2008-05-27	2009-12-02	北京瑞伊人科技发展有限公司	A kind of metformin hydrochloride/voigelibo sugar-lowering oral preparation compositions and preparation thereof
KR101189639B1 (en) *	2008-12-15	2012-10-12	씨제이제일제당 (주)	Oral formulations comprising metformin and &-glycosidase inhibitor and processes for the preparation thereof
CN102133402B (en) *	2011-03-24	2013-06-12	首都医科大学附属北京同仁医院	Application of cystic fibrosis transmembrane transduction regulating factor inhibitor to preparation of medicaments for treating diabetes

2013
- 2013-03-06 KR KR1020130024157A patent/KR101336499B1/en not_active Expired - Fee Related
2014
- 2014-02-24 HK HK16100385.5A patent/HK1212587A1/en unknown
- 2014-02-24 EP EP14760276.7A patent/EP2964211A4/en not_active Withdrawn
- 2014-02-24 JP JP2015559188A patent/JP2016509065A/en active Pending
- 2014-02-24 WO PCT/KR2014/001455 patent/WO2014137090A1/en not_active Ceased
- 2014-02-24 PH PH1/2014/500736A patent/PH12014500736A1/en unknown
- 2014-02-24 BR BR112015018934A patent/BR112015018934A2/en not_active IP Right Cessation
- 2014-02-26 TW TW103106464A patent/TW201434463A/en unknown
- 2014-03-05 CN CN201410078942.1A patent/CN104027328A/en active Pending

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ANONYMOUS: "Metformin Hydrochloride and voglibose tablets", 1 May 2011 (2011-05-01), pages 1 - 2, XP055291054, Retrieved from the Internet <URL:http://www.biocon.com/docs/prescribing_information/diabetology/metadozev_pi.pdf> [retrieved on 20160725] *
See also references of WO2014137090A1 *

Also Published As

Publication number	Publication date
KR101336499B1 (en)	2013-12-03
BR112015018934A2 (en)	2017-07-18
TW201434463A (en)	2014-09-16
PH12014500736A1 (en)	2014-06-30
CN104027328A (en)	2014-09-10
JP2016509065A (en)	2016-03-24
EP2964211A1 (en)	2016-01-13
HK1212587A1 (en)	2016-06-17
WO2014137090A1 (en)	2014-09-12

Legal Events

Date	Code	Title	Description
2015-12-11	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2016-01-13	17P	Request for examination filed	Effective date: 20151006
2016-01-13	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
2016-01-13	AX	Request for extension of the european patent	Extension state: BA ME
2016-06-15	DAX	Request for extension of the european patent (deleted)
2016-06-17	REG	Reference to a national code	Ref country code: HK Ref legal event code: DE Ref document number: 1212587 Country of ref document: HK
2016-08-31	A4	Supplementary search report drawn up and despatched	Effective date: 20160803
2016-08-31	RIC1	Information provided on ipc code assigned before grant	Ipc: A61K 31/133 20060101ALI20160728BHEP Ipc: A61K 31/155 20060101AFI20160728BHEP Ipc: A61P 3/10 20060101ALI20160728BHEP Ipc: A61K 31/7028 20060101ALI20160728BHEP
2017-04-09	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE
2017-08-25	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2017-09-27	18D	Application deemed to be withdrawn	Effective date: 20170302
2022-09-16	REG	Reference to a national code	Ref country code: HK Ref legal event code: WD Ref document number: 1212587 Country of ref document: HK

Publication	Publication Date	Title
EP2875824A4 (en)	2016-03-23	COMPOSITION FOR THE PREVENTION OR TREATMENT OF CACHEXIA
EP2818483A4 (en)	2015-09-02	MEDICINAL COMPOSITION FOR THE TREATMENT AND / OR PREVENTION OF CANCER
EP3370703A4 (en)	2019-06-19	COMBINATION OF GEMCABEN FOR THE TREATMENT OF CARDIOVASCULAR DISEASES
EP3013345A4 (en)	2016-11-30	COMPOUNDS FOR THE TREATMENT OF SPINAL AMYOTROPHY
EP3377068A4 (en)	2019-06-19	POLYTHERAPY COMPRISING TETRACYCLIC QUINOLONE ANALOGUES FOR THE TREATMENT OF CANCER
EP3004083A4 (en)	2016-11-16	COMPOUNDS FOR THE TREATMENT OF DRUG RESISTANT AND PERSISTENT TUBERCULOSIS
EP2872151A4 (en)	2016-04-13	ACELLULAR PRO-TOLEROGENIC COMPOSITIONS FOR THE TREATMENT OR PREVENTION OF AUTOIMMUNE DISEASES
EP2818482A4 (en)	2015-10-07	PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND / OR PREVENTION OF CANCER
EP2824114A4 (en)	2015-10-07	PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND / OR PREVENTION OF CANCER
EP2818481A4 (en)	2015-10-07	PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND / OR PREVENTION OF CANCER
EP3919030C0 (en)	2024-08-14	IMPLANTABLE DEVICE FOR THE TREATMENT OF GLAUCOMA
EP3025716A4 (en)	2016-10-19	SUBSTANCE FOR THE TREATMENT OR RELIEF OF PAIN
EP2991673A4 (en)	2016-12-21	INJECTABLE NANORESIN GELS FOR THE TREATMENT OF DIABETES
EP2957282A4 (en)	2016-10-05	ORAL ANTISEPTIC COMPOSITION FOR THE TREATMENT OF ORAL MUCOSITIS
EP3335041A4 (en)	2019-05-15	BIOMARKERS FOR THE TREATMENT OF PELADE
HUE037179T2 (en)	2018-08-28	Pharmaceutical compositions for the treatment of muscle disorders
EP2959903A4 (en)	2016-08-03	MEDICATION FOR THE TREATMENT OF EYE DISEASE
FR20C1044I2 (en)	2021-10-15	TRIAZINES FOR THE TREATMENT OF PROTOZOIC INFECTIONS
MA39927A (en)	2017-03-08	GLYT1 INHIBITORS FOR THE TREATMENT OF BLOOD DISORDERS
EP4223359C0 (en)	2026-02-18	NON-INVASIVE DEVICE FOR THE TREATMENT OF PATHOLOGICAL GASTROPHAGEAL REFLUX
EP2968478A4 (en)	2016-09-07	COMPOSITIONS AND METHODS FOR THE TREATMENT OF CARBOXYHEMOGLOBINEMIA
EP2964750A4 (en)	2016-08-17	METHODS AND COMPOSITIONS FOR THE TREATMENT AND / OR PREVENTION OF TYPE 1 DIABETES
EP2536436A4 (en)	2015-01-14	ANTIMIR-451 FOR THE TREATMENT OF POLYCYTHEMICS
EP2886122A4 (en)	2016-05-18	AGENT FOR THE TREATMENT OF CANCER
FR3015285B1 (en)	2016-07-22	FORMULATION FOR THE TREATMENT OF HAIR